NORDEA INVESTMENT MANAGEMENT AB
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1218210
STOCKHOLM, V7
Position in ALNY
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$8,101,620
+$3,685,829 QoQ
Shares Held
26,913
+101.7% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#208
of 784 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORDEA INVESTMENT MANAGEMENT AB holds $503,679,873 across 20 Biotechnology names. ALNY ranks #7 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
363,479 | $226,643,694 | |
| 2 | RPRX |
Royalty Pharma plc
|
2,576,772 | $144,479,604 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
284,175 | $23,163,103 | |
| 4 | LGND |
Ligand Pharmaceuticals Inc
|
49,943 | $15,786,482 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
30,496 | $15,148,278 | |
| 6 | EXEL |
Exelixis, Inc.
|
210,314 | $11,443,184 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
26,913 | $8,101,620 | |
| 8 | PTGX |
Protagonist Therapeutics, Inc
|
64,964 | $7,963,286 |
All Filings in ALNY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,101,620 | 26,913 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $4,415,791 | 13,346 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $5,111,790 | 12,855 | Shares | Defined | 2026-01-08 | |
| 2025-09-30 | $5,691,336 | 12,481 | Shares | Defined | 2025-10-27 | |
| 2025-06-30 | $3,683,186 | 11,295 | Shares | Defined | 2025-07-29 | |
| 2025-03-31 | $2,763,654 | 10,235 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $2,397,337 | 10,188 | Shares | Sole | 2025-01-06 | |
| 2024-09-30 | $2,626,811 | 9,551 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $2,292,462 | 9,434 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $1,342,061 | 8,980 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $1,663,352 | 8,690 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $1,538,999 | 8,690 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,600,624 | 8,427 | Shares | Sole | 2023-07-07 | |
| 2023-03-31 | $1,731,365 | 8,643 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $2,031,194 | 8,547 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $1,451,960 | 7,254 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $1,042,827 | 7,150 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $1,123,108 | 6,878 | Shares | Sole | 2022-04-11 | |
| 2021-12-31 | $1,211,818 | 7,146 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $972,749 | 5,152 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $873,367 | 5,152 | Shares | Sole | 2021-07-16 | |
| 2021-03-31 | $727,410 | 5,152 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $704,697 | 5,422 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $789,443 | 5,422 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $1,606,104 | 10,844 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $518,670 | 4,765 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||